Ipsen SA (France) Top Management

IPN Stock  EUR 109.40  0.10  0.09%   
Ipsen SA employs about 5 K people. The company is managed by 32 executives with a total tenure of roughly 195 years, averaging almost 6.0 years of service per executive, having 156.25 employees per reported executive. Analysis of Ipsen SA's management performance can provide insight into the company performance.
Richard Paulson  CEO
Executive Vice President and Chief Executive Officer of Ipsen North America
David Loew  CEO
Chief Executive Officer, Director
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ipsen SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ipsen SA Management Team Effectiveness

The company has return on total asset (ROA) of 0.1026 % which means that it generated a profit of $0.1026 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1944 %, meaning that it generated $0.1944 on every $100 dollars invested by stockholders. Ipsen SA's management efficiency ratios could be used to measure how well Ipsen SA manages its routine affairs as well as how well it operates its assets and liabilities.

Ipsen SA Workforce Comparison

Ipsen SA is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 144,118. Ipsen SA holds roughly 5,000 in number of employees claiming about 3% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28.

Ipsen SA Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Ipsen SA Price Series Summation is a cross summation of Ipsen SA price series and its benchmark/peer.

Ipsen SA Notable Stakeholders

An Ipsen SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ipsen SA often face trade-offs trying to please all of them. Ipsen SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ipsen SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Richard PaulsonExecutive Vice President and Chief Executive Officer of Ipsen North AmericaProfile
David LoewChief Executive Officer, DirectorProfile
Aymeric ChatelierInterim Chief Executive Officer, Chief Financial Officer, Executive Vice PresidentProfile
Marc GaridelChairman, CEO and Chairman of Strategic CommitteeProfile
Antoine FlochelVice Chairman of the BoardProfile
Francois GarnierExecutive Vice President General Counsel, Member of the Executive CommitteeProfile
Dominique BeryExecutive Vice President, Strategy and TransformationProfile
Yan MooreSenior Vice President Head of Oncology Therapeutics AreaProfile
Aidan MurphyExecutive Vice-President Technical OperationsProfile
Howard MayerExecutive Vice President, Head of Research & DevelopmentProfile
Regis MulotChief Human Resource Officer, Executive Vice PresidentProfile
Alexander McEwanVice President and Head of RadiopharmaceuticalsProfile
Ivana MagovcevicLiebischExecutive Vice President Chief Business OfficerProfile
Harout SemerjianExecutive Vice President & President Specialty Care International & Global FranchisesProfile
Benoit HennionExecutive Vice President and President Consumer HelathcareProfile
Dominique LaymandExecutive Vice President, Chief Ethics and Compliance OfficerProfile
Henri BeaufourDirectorProfile
Carol XuerefIndependent DirectorProfile
Margaret LiuIndependent DirectorProfile
Philippe BonhommeDirector, Permanent representative of Beech Tree SAProfile
Michele OllierIndependent DirectorProfile
Carol StuckleyIndependent DirectorProfile
JeanMarc ParantDirector, representing EmployeesProfile
Anne BeaufourDirector, Permanent representative of Highrock S.àr.l.Profile
Paul SekhriIndependent DirectorProfile
Gwenan WhiteExecutive Vice President Communications and Public AffairsProfile
Piet WigerinckIndependent DirectorProfile
Craig MarksVicePres RelationsProfile
Yan MDVP AreaProfile
Steven HildemannExecutive Vice President Chief Medical Officer, Head of Global Medical Affairs and PharmacovigilanceProfile
Philippe LopesFernandesExecutive Vice President Chief Business OfficerProfile
Stephan GagneHead OfficeProfile

About Ipsen SA Management Performance

The success or failure of an entity such as Ipsen SA often depends on how effective the management is. Ipsen SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ipsen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ipsen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Ipsen S.A. operates as a biopharmaceutical company worldwide. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. IPSEN operates under Drug ManufacturersSpecialty Generic classification in France and is traded on Paris Stock Exchange. It employs 5700 people.
Please note, the presentation of Ipsen SA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ipsen SA's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ipsen SA's management manipulating its earnings.

Ipsen SA Workforce Analysis

Traditionally, organizations such as Ipsen SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ipsen SA within its industry.

Ipsen SA Manpower Efficiency

Return on Ipsen SA Manpower

Revenue Per Employee631.3K
Revenue Per Executive98.6M
Net Income Per Employee118.4K
Net Income Per Executive18.5M
Working Capital Per Employee69.6K
Working Capital Per Executive10.9M

Complementary Tools for Ipsen Stock analysis

When running Ipsen SA's price analysis, check to measure Ipsen SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ipsen SA is operating at the current time. Most of Ipsen SA's value examination focuses on studying past and present price action to predict the probability of Ipsen SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ipsen SA's price. Additionally, you may evaluate how the addition of Ipsen SA to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Share Portfolio
Track or share privately all of your investments from the convenience of any device